文献速递瓣膜病与结构性心脏病

疑似心脏肿瘤的心血管磁共振成像:一项多中心结局研究

Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study.
PubMed 文献 · Eur Heart J · 2021-01-01

本研究为多中心结局研究,纳入903例因疑似心脏肿瘤接受临床心血管磁共振(CMR)检查的患者,将CMR诊断分为无肿块、假性肿块、血栓、良性肿瘤和恶性肿瘤。中位随访4.9年,376例死亡;

要点

  • CMR对疑似心脏肿瘤诊断准确率高,与最终诊断一致率达98.4%。
  • 无肿块、假性肿块和良性肿瘤患者长期死亡率相似。
  • 恶性肿瘤和血栓患者死亡率显著更高,CMR诊断独立预测死亡。

核心结论

  • 在疑似心脏肿瘤患者中,CMR诊断准确率高,无肿块、假性肿块和良性肿瘤患者长期死亡率相似,恶性肿瘤和血栓患者死亡率更高,CMR诊断是独立于临床因素的死亡预测因子。

研究设计与样本

  • 多中心结局研究,纳入903例因疑似心脏肿瘤接受临床CMR检查的患者,CMR诊断分为无肿块、假性肿块、血栓、良性肿瘤和恶性肿瘤,主要终点为全因死亡。

主要发现

  • 903例患者中CMR诊断为无肿块占25%、假性肿块占16%、血栓占16%、良性肿瘤占17%、恶性肿瘤占23%。
  • 中位随访4.9年,376例患者死亡。
  • CMR诊断与最终诊断一致率为98.4%。
  • CMR诊断在左心室射血分数、冠心病和心外恶性肿瘤病史等临床因素之上提供增量预后价值(P<0.001)。

临床怎么用

  • 对于疑似心脏肿瘤患者,CMR可用于准确鉴别无肿块、假性肿块、血栓、良性肿瘤和恶性肿瘤。
  • CMR诊断为无肿块、假性肿块或良性肿瘤的患者长期死亡风险相似,可据此避免不必要的进一步检查。
  • CMR诊断恶性肿瘤或血栓提示死亡风险升高,应加强临床关注和随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Cardiovascular magnetic resonance (CMR) imaging is a key diagnostic tool for the evaluation of patients with suspected cardiac tumours. Patient management is guided by the CMR diagnosis, including no further testing if a mass is excluded or if only a pseudomass is found. However, there are no outcomes studies validating this approach. METHODS AND RESULTS: In this multicentre study of patients undergoing clinical CMR for suspected cardiac tumour, CMR diagnoses were assigned as no mass, pseudomass, thrombus, benign tumour, or malignant tumour. A final diagnosis was determined after follow-up using all available data. The primary endpoint was all-cause mortality. Among 903 patients, the CMR diagnosis was no mass in 25%, pseudomass in 16%, thrombus in 16%, benign tumour in 17%, and malignant tumour in 23%. Over a median of 4.9 years, 376 patients died. Compared with the final diagnosis, the CMR diagnosis was accurate in 98.4% of patients. Patients with CMR diagnoses of pseudomass and benign tumour had similar mortality to those with no mass, whereas those with malignant tumour [hazard ratio (HR) 3.31 (2.40-4.57)] and thrombus [HR 1.46 (1.00-2.11)] had greater mortality. The CMR diagnosis provided incremental prognostic value over clinical factors including left ventricular ejection fraction, coronary artery disease, and history of extracardiac malignancy (P < 0.001). CONCLUSION: In patients with suspected cardiac tumour, CMR has high diagnostic accuracy. Patients with CMR diagnoses of no mass, pseudomass, and benign tumour have similar long-term mortality. The CMR diagnosis is a powerful independent predictor of mortality incremental to clinical risk factors.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Shenoy C, Grizzard JD, Shah DJ, et al. Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study. Eur Heart J. 2021. PMID: 34545397. doi:10.1093/eurheartj/ehab635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。